Pre-market Hot Trades in US Stocks
OFA is down 7.69% in pre-market trading. Based on recent news,
<ol>
<li>
On May 14, OFA Group announced the signing of a $7.5 million tokenized platform service agreement for a residential development project in Vero Beach, Florida. Following this announcement, the market expressed concerns about the project's prospects, leading to a decline in stock price.
</li>
<li>
There have been no other significant news recently. The market's reaction to new projects has been cautious, and further developments should be monitored.
</li>
</ol>
Lobo Tech is up 7.67% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, Lobo Technologies Ltd. surged 33.70% in after-hours trading, with the stock price rising to $0.69, reversing an intraday decline of 8.43%. The catalyst for this increase is unclear, but the company recently announced the launch of the Claw AI Agent platform, which integrates a 1.6 trillion parameter MoE model, DeepSeek V4, OpenAI, and Google Gemini, aimed at enterprise automation applications. This news may have sparked investor interest. Source: Benzinga
</li>
<li>
On May 4, Lobo announced the launch of its Claw AI Agent platform, integrating multiple advanced AI technologies, targeting enterprise automation applications. This innovation may have driven positive stock performance. Source: Benzinga
</li>
<li>
Recently, Lobo has been actively considering external business opportunities, which may further enhance market expectations for its future growth. Source: Benzinga The electric mobility product industry has been active recently.
</li>
</ol>
Top Gainers in Pre-market US Stocks
HCW Biologics is up 123.09% in pre-market trading. Based on recent key news:
<ol>
<li>
On May 14, HCW Biologics announced that its drug HCW11-040 has been activated for IND research to prevent bronchopulmonary dysplasia (BPD), with research expected to be completed in the second half of 2027 and an IND application submitted. This progress has boosted market confidence in the company's future development, driving a significant increase in stock price. Source: Reuters
</li>
<li>
On May 14, HCW Biologics released its Q1 2026 financial report, showcasing the company's innovative achievements in autoimmune diseases, cancer, and age-related developmental disorders. The positive performance of the financial report further enhanced investor confidence. Source: Company announcement
</li>
<li>
On May 14, analysts rated HCW Biologics as &#34;Buy,&#34; predicting a 12-month price target of $2.00, which is 472.4% higher than the closing price of $0.35 on May 13. This optimistic analyst expectation has provided strong support for the stock price. Source: Reuters The biotechnology industry has been active recently, with significant capital inflows
Dreamland pre-market up 95%. Based on recent key news:
</li>
<li>
On May 12, Dreamland signed a memorandum of understanding with LinkFung Innovation to develop an AI-driven smart image library platform. This move is seen as an important step for the company to strategically expand its market influence, driving up the stock price.
</li>
<li>
On May 13, Dreamland's stock price surged by 126.92%, with a transaction amount of approximately $219 million, indicating an extremely rare influx of capital. Market sentiment showed clear speculative characteristics, with speculative funds concentrating in, leading to significant stock price volatility.
</li>
<li>
On May 14, technical indicators showed that the stock price was severely overbought, with an RSI of 97.75, and the stock price far above key moving averages. Market optimism was high, but there was a risk of a pullback. The film and entertainment industry had no significant positive news recently.
</li>
</ol>
Murano Global BV pre-market up 70.58%. Based on recent key news:
<ol>
<li>
On May 11, Murano Global Investments submitted Form 3, showing that CEO Sacal Cababie Elias holds 69,152,609 shares of common stock. The disclosure of this holding information may enhance market confidence in the company's management, driving up the stock price.
</li>
<li>
On May 11, Murano Global Investments appointed Oscar Jazmani Mendoza Escobar as Chief Financial Officer. The newly appointed executive may be seen by the market as a positive signal for the company's future development, further stimulating the stock price increase.
</li>
<li>
On May 11, Murano Global Investments appointed Marcos Sacal Cohen as Chief Operating Officer and Director. This appointment may be interpreted as a strategic adjustment of the company's management, enhancing investors' confidence in the company's operational capabilities, boosting the stock price. The market reacted positively to the management changes, driving the stock price up significantly
</li>
</ol>

OFAL

LOBO

OFA pre-market down 7.69%; Lobo Tech pre-market up 7.67%; HCW Biologics pre-market up 123.09%; Dreamland pre-market up 95.00%; Murano Global BV pre-market up 70.58%

Price Alert

Pre-market hot trades in US stocks: OFA pre-market down 7.69%; Lobo Tech pre-market up 7.67%